By WASHINGTON UNIVERSITY SCHOOL OF MEDICINE APRIL 24, 2023 A study at Washington University School of Medicine in St. Louis has shown that the FDA-approved insomnia medication suvorexant may reduce key Alzheimer’s proteins in the brain. Participants who took a higher dose of the drug experienced a significant drop in amyloid and hyperphosphorylated tau levels. However, the...
